| Karen Moon, DPM | |
|
2701 N Decatur Rd, Decatur, GA 30033-5918 | |
| (404) 501-2499 | |
| Not Available |
| Full Name | Karen Moon |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 8 Years |
| Location | 2701 N Decatur Rd, Decatur, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417458357 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | POD001356 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth New Smyrna Beach | New smyrna beach, FL | Hospital |
| Adventhealth Daytona Beach | Daytona beach, FL | Hospital |
| Halifax Health Medical Center | Daytona beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upperline Healthcare Pc | 4385900653 | 117 |
News Archive
BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.
Glucosamine supplements may reduce overall mortality about as well as regular exercise does, according to a new epidemiological study from West Virginia University.
Over the last few years, the use of nanomaterials for water treatment, food packaging, pesticides, cosmetics and other industries has increased. For example, farmers have used silver nanoparticles as a pesticide because of their capability to suppress the growth of harmful organisms. However, a growing concern is that these particles could pose a potential health risk to humans and the environment.
Scientists at The Scripps Research Institute have discovered a potential new use for the drug closantel, currently the standard treatment for sheep and cattle infected with liver fluke. The new research suggests that the drug may be useful in combating river blindness, a tropical disease that is the world's second leading infectious cause of blindness for humans.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Tablets, 10 mg, the generic version of Merck's Singulair Tablets.
› Verified 3 days ago
| Provider Name | Upperline Healthcare Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538686498 PECOS PAC ID: 4385900653 Enrollment ID: O20201109001904 |
News Archive
BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.
Glucosamine supplements may reduce overall mortality about as well as regular exercise does, according to a new epidemiological study from West Virginia University.
Over the last few years, the use of nanomaterials for water treatment, food packaging, pesticides, cosmetics and other industries has increased. For example, farmers have used silver nanoparticles as a pesticide because of their capability to suppress the growth of harmful organisms. However, a growing concern is that these particles could pose a potential health risk to humans and the environment.
Scientists at The Scripps Research Institute have discovered a potential new use for the drug closantel, currently the standard treatment for sheep and cattle infected with liver fluke. The new research suggests that the drug may be useful in combating river blindness, a tropical disease that is the world's second leading infectious cause of blindness for humans.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Tablets, 10 mg, the generic version of Merck's Singulair Tablets.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen Moon, DPM 2701 N Decatur Rd, Decatur, GA 30033-5918 Ph: () - | Karen Moon, DPM 2701 N Decatur Rd, Decatur, GA 30033-5918 Ph: (404) 501-2499 |
News Archive
BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.
Glucosamine supplements may reduce overall mortality about as well as regular exercise does, according to a new epidemiological study from West Virginia University.
Over the last few years, the use of nanomaterials for water treatment, food packaging, pesticides, cosmetics and other industries has increased. For example, farmers have used silver nanoparticles as a pesticide because of their capability to suppress the growth of harmful organisms. However, a growing concern is that these particles could pose a potential health risk to humans and the environment.
Scientists at The Scripps Research Institute have discovered a potential new use for the drug closantel, currently the standard treatment for sheep and cattle infected with liver fluke. The new research suggests that the drug may be useful in combating river blindness, a tropical disease that is the world's second leading infectious cause of blindness for humans.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Tablets, 10 mg, the generic version of Merck's Singulair Tablets.
› Verified 3 days ago
Dr. Suzette Andrean Clements, D.P.M., Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4535 Flat Shoals Pkwy, Suite # 301, Decatur, GA 30034 Phone: 404-381-3600 Fax: 404-381-4900 | |
Dr. Jimmy Lee Gregory, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3546 Covington Hwy, Suite C, Decatur, GA 30032 Phone: 404-284-7744 Fax: 404-284-8006 | |
Greenbriar Foot & Ankle Center Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4480 Covington Highway, Suite A, Decatur, GA 30034 Phone: 404-288-4117 Fax: 404-288-8451 | |
Flat Shoals Foot & Ankle Center, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 2855 Candler Rd, Suite 10, Decatur, GA 30034 Phone: 404-241-7400 Fax: 404-241-7475 | |
Dr. Thomas Douglas Cain, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2801 N Decatur Rd Ste 295, Decatur, GA 30033 Phone: 404-778-0204 Fax: 404-544-1479 | |
Allied Ankle & Footcare Centers Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2784 N Decatur Rd, Suite 150, Decatur, GA 30033 Phone: 404-298-6050 Fax: 404-508-0648 | |
Dr. Lauren K Hill, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2701 N Decatur Rd, Decatur, GA 30033 Phone: 404-501-1000 |